As a thymidine phosphorylase inhibitor15, 16, 17, 18, 19, GLB is shown to reduce the production and secretion of vascular endothelial growth factor (VEGF), suppress the formation of new blood vessels and especially block the tumor angiogenesis, growth and metastasis in vivo20. This evidence concerns the gene VEGFA and neoplasm.